CAD 0.37
(1.39%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -22.99 Million USD | 253.17% |
2022 | -30.9 Million USD | -177.38% |
2021 | 39.94 Million USD | 181.09% |
2020 | -49.25 Million CAD | 24.26% |
2019 | -65.03 Million CAD | -131.0% |
2018 | -28.15 Million CAD | -322.99% |
2017 | -6.65 Million CAD | -667.79% |
2016 | -866.94 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 12.61 Million USD | 9.98% |
2024 Q1 | 11.47 Million USD | -27.28% |
2023 Q4 | 15.77 Million USD | -25.74% |
2023 Q1 | 5.6 Million USD | -50.57% |
2023 Q2 | 4.71 Million USD | -15.88% |
2023 Q3 | 21.24 Million USD | 350.99% |
2023 FY | 47.34 Million USD | 253.17% |
2022 Q3 | -10.51 Million CAD | 41.17% |
2022 Q1 | -12.7 Million CAD | 47.93% |
2022 FY | -30.9 Million USD | -177.38% |
2022 Q4 | 11.33 Million CAD | 207.71% |
2022 Q2 | -17.88 Million CAD | -40.76% |
2021 Q4 | -24.39 Million CAD | 2.7% |
2021 FY | 39.94 Million USD | 181.09% |
2021 Q3 | -25.07 Million CAD | 0.0% |
2020 FY | -49.25 Million CAD | 24.26% |
2019 FY | -65.03 Million CAD | -131.0% |
2018 FY | -28.15 Million CAD | -322.99% |
2017 FY | -6.65 Million CAD | -667.79% |
2016 FY | -866.94 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aurora Cannabis Inc. | -46.45 Million CAD | 50.496% |
Avicanna Inc. | -7.93 Million CAD | -189.877% |
Avant Brands Inc. | -1.45 Million CAD | -1484.838% |
Cardiol Therapeutics Inc. | -29.78 Million CAD | 22.795% |
Crescita Therapeutics Inc. | -1.95 Million CAD | -1075.665% |
Knight Therapeutics Inc. | -2.89 Million CAD | -695.709% |
MediPharm Labs Corp. | -18.25 Million CAD | -25.992% |
OrganiGram Holdings Inc. | -242.73 Million CAD | 90.526% |
Canopy Growth Corporation | -228.71 Million CAD | 89.946% |
Willow Biosciences Inc. | -13.18 Million CAD | -74.45% |
Auxly Cannabis Group Inc. | -19 Million CAD | -21.0% |